You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 55 No. 12, December 1998 TABLE OF CONTENTS
  Archives
  •  Online Features
  Original Contribution
 This Article
 •Full text
 •PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on ISI (25)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Topic Collections
 •Neurogenetics
 •Movement Disorders
 •Parkinson Disease/ Parkinsonian Disorders
 •Alert me on articles by topic

The G209A Mutation in the {alpha}-Synuclein Gene Is Not Detected in Familial Cases of Parkinson Disease in Non-Greek and/or Italian Populations

William W. Wang, MD, PhD; Mehrdad Khajavi, BS; Bhavna J. Patel, BS; Jennifer Beach, RN; Joseph Jankovic, MD; Tetsuo Ashizawa, MD

Arch Neurol. 1998;55:1521-1523.

Objective  To determine whether the G-to-A substitution at nucleotide 209 (G209A) mutation in the {alpha}-synuclein gene is responsible for familial Parkinson disease (PD) in the US population.

Design  Polymerase chain reaction–based DNA analysis of consecutive patients with PD and family history of PD.

Setting  A university-affiliated movement disorder clinic and a Veterans Affairs clinical research laboratory.

Patients  Forty-four patients with PD and family history of PD and 29 patients with sporadic PD, all with no known Greek and/or Italian background.

Results  None of the DNA samples showed the G209A mutation.

Conclusion  The G209A mutation is rare in US patients with familial PD.


From the Veterans Affairs Medical Center (Drs Wang, Khajavi, Patel, and Ashizawa) and the Department of Neurology, Baylor College of Medicine (Drs Wang, Beach, Jankovic, and Ashizawa), Houston, Tex.



THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Clinical phenotype in patients with {alpha}-synuclein Parkinson's disease living in Greece in comparison with patients with sporadic Parkinson's disease
Papapetropoulos et al.
J. Neurol. Neurosurg. Psychiatry 2001;70:662-665.
ABSTRACT | FULL TEXT  

Variability and validity of polymorphism association studies in Parkinson's disease
Tan et al.
Neurology 2000;55:533-538.
ABSTRACT | FULL TEXT  

Polymorphism of NACP-Rep1 in Parkinson's disease: An etiologic link with essential tremor?
Tan et al.
Neurology 2000;54:1195-1198.
ABSTRACT | FULL TEXT  

Therapeutics in the Neurorehabilitation of Parkinson's Disease
Colcher and Stern
Neurorehabil Neural Repair 1999;13:205-218.
ABSTRACT  

Induction of Neuronal Cell Death by Rab5A-dependent Endocytosis of alpha -Synuclein
Sung et al.
J. Biol. Chem. 2001;276:27441-27448.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1998 American Medical Association. All Rights Reserved.